Subscribe To
FLXN / FLXN Stock: Why It Substantially Increased Today
FLXN News
By Business Wire
October 11, 2021
Flexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Flexion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – FLXN
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Flexion Therapeutics, Inc. (NASDA more_horizontal
By Business Wire
October 11, 2021
Flexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Flexion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – FLXN
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Flexion Therapeutics, Inc. (NASDA more_horizontal
By Business Wire
October 11, 2021
Flexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Flexion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – FLXN
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Flexion Therapeutics, Inc. (NASDA more_horizontal
By Pulse2
October 11, 2021
FLXN Stock: Why It Substantially Increased Today
The stock price of Flexion Therapeutics Inc (NASDAQ: FLXN) increased by over 65% pre-market today. This is why it happened. more_horizontal
By Pulse2
October 11, 2021
FLXN Stock: Why It Substantially Increased Today
The stock price of Flexion Therapeutics Inc (NASDAQ: FLXN) increased by over 65% pre-market today. This is why it happened. more_horizontal
By Pulse2
October 11, 2021
FLXN Stock: Why It Substantially Increased Today
The stock price of Flexion Therapeutics Inc (NASDAQ: FLXN) increased by over 65% pre-market today. This is why it happened. more_horizontal
By GlobeNewsWire
October 11, 2021
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain p more_horizontal
By GlobeNewsWire
October 11, 2021
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain p more_horizontal
